These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1053378)

  • 21. [Practical use of immunosuppressive and cytostatic drugs in dermatological diseases].
    Schuppli R
    Minerva Med; 1970 Jul; 61(55):3070-3. PubMed ID: 5427679
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunosuppressant drugs in dermatology (author's transl)].
    Christeler A; Delacrétaz J
    Ther Umsch; 1979 May; 36(5):456-62. PubMed ID: 451959
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunosuppressive treatment of skin diseases. II. Clinical use of immunosuppressive drugs].
    Ruszczak Z
    Przegl Dermatol; 1974; 61(4):529-35. PubMed ID: 4603603
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunosuppressive agents in dermatology].
    Schuppli R
    Dtsch Med Wochenschr; 1970 Dec; 95(51):2576-7. PubMed ID: 5513651
    [No Abstract]   [Full Text] [Related]  

  • 25. Azathioprine in dermatology: a survey of current practice in the U.K.
    Tan BB; Lear JT; Gawkrodger DJ; English JS
    Br J Dermatol; 1997 Mar; 136(3):351-5. PubMed ID: 9115914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psoriasis and bullous pemphigoid treated with azathioprine.
    Primka EJ; Camisa C
    J Am Acad Dermatol; 1998 Jul; 39(1):121-3. PubMed ID: 9674409
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunosuppressive agents in dermatology.
    Ho VC; Zloty DM
    Dermatol Clin; 1993 Jan; 11(1):73-85. PubMed ID: 8435920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate mofetil.
    Zwerner J; Fiorentino D
    Dermatol Ther; 2007; 20(4):229-38. PubMed ID: 17970888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive agents in dermatology. An update.
    Dutz JP; Ho VC
    Dermatol Clin; 1998 Apr; 16(2):235-51. PubMed ID: 9589197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive drugs in dermatology--benefits and threats.
    Kowal A; Warmińska J; Krasowska D
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):14-21. PubMed ID: 15323159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutics. XI. Immunosuppressive drugs.
    Ashton H; Beveridge GW; Stevenson CJ
    Br J Dermatol; 1970 Aug; 83(2):326-30. PubMed ID: 4916789
    [No Abstract]   [Full Text] [Related]  

  • 32. Azathioprine monotherapy in autoimmune blistering diseases: A feasible option for mild to moderate cases.
    Kakuta R; Yamagami J; Funakoshi T; Takahashi H; Ohyama M; Amagai M
    J Dermatol; 2018 Mar; 45(3):334-339. PubMed ID: 29250862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Childhood Bullous Pemphigoid: A Treatment Challenge.
    Ayala-Cortés AS; Martínez-Cabriales SA; Welsh O; Rosales-Solis G; Vázquez-Martínez O; Ocampo-Candiani J
    J Pediatr; 2016 Dec; 179():271-271.e1. PubMed ID: 27697329
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid.
    Gürcan HM; Ahmed AR
    Br J Dermatol; 2009 Oct; 161(4):723-31. PubMed ID: 19548961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azathioprine.
    Ahmed AR; Moy R
    Int J Dermatol; 1981 Sep; 20(7):461-7. PubMed ID: 7026466
    [No Abstract]   [Full Text] [Related]  

  • 37. Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low-dose methotrexate.
    Wang TS; Tsai TF
    Acta Derm Venereol; 2014 Jan; 94(1):108-9. PubMed ID: 23624752
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ; Amin KG
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluocinolone acetonide 0.2 per cent cream--a co-operative clinical trial.
    Marsden CW
    Br J Dermatol; 1968 Sep; 80(9):614-7. PubMed ID: 4877599
    [No Abstract]   [Full Text] [Related]  

  • 40. [The pathophysiological disorders and experimental therapy in pemphigus and pemphigoid].
    Grando SA; Glukhen'kiĭ BT; Barabash TM; Zaslavskiĭ LI; Cherniavskiĭ AI
    Vestn Dermatol Venerol; 1990; (11):4-9. PubMed ID: 2288153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.